Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Molecular Endocrinology (Baltimore, Md.)|October 4, 2003
Position of Pro and Ser near Glu7.32 in the extracellular loop 3 of mammalian and nonmammalian gonadotropin-releasing hormone (GnRH) receptors is a critical determinant for differential ligand selectivity for mammalian GnRH and chicken GnRH-IIChengbing Wang, Oim Yun, Kaushik Maiti, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2022
Novel allosteric glutaminase 1 inhibitors with macrocyclic structure activity relationship analysisEun Ji Lee, Krishna Babu Duggirala, Yujin Lee, et al.
BMC Cancer|January 24, 2016
Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cellsChi Hoon Park, Sung Yun Cho, Jae Du Ha, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2013
Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitorsSung Yun Cho, Byung Ho Lee, Heejung Jung, et al.
Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and OocytesMinsung Kang, Chijung Kim, Jiyeon Leem, et al.
Toxicology and Applied Pharmacology|December 31, 2013
A novel assessment of nefazodone-induced hERG inhibition by electrophysiological and stereochemical methodDae-Seop Shin, Myoung Joo Park, Hyang-Ae Lee, et al.
Archives of Pharmacal Research|January 22, 2014
ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatmentHyeon Ji Lee, Muhammad Latif, Hyeonjeong Choe, et al.
Acta Pharmaceutica Sinica. B|March 27, 2023
A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathwaySae-Bom Yoon, Hyowon Hong, Hee-Jong Lim, et al.
Archives of Pharmacal Research|October 17, 2013
Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activitiesJeong In Yun, Eun Hye Yang, Muhammad Latif, et al.
European Journal of Medicinal Chemistry|December 22, 2023
DW71177: A novel [1,2,4]triazolo[4,3-a]quinoxaline-based potent and BD1-Selective BET inhibitor for the treatment of acute myeloid leukemiaImran Ali, Hyung Jin Cha, Byungho Lim, et al.
Pageof 4